Skip to content

Effect of Fenugreek, Cranberries, Chicory and Nettle seed extracts on blood glucose in type 2 diabetic patients

Effect of Fenugreek, Cranberries, Chicory and Nettle seed extract on blood glucose in type 2 diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190112042332N1
Enrollment
100
Registered
2019-01-26
Start date
2017-09-23
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose Control in Type 2 Diabetic patients. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Two Capsule containing one fourth of the effective dose of four medicinal herbs. Intervention 2: Control group: Two Capsule containing Rye bread powder, 1000 mg tw

Sponsors

Bagheiat-allah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Male and female subjects between 20 and 70 years of age Noninsulin-dependent diabetes minimum of 2 years before the study enrollment Patients with diabetes Type 2 and on any antidiabetic medication (oral hypoglycemic agent, insulin) Patients willing to give informed consent Patients with out other comorbid conditions (cardiac, renal, macrovascular and microvascular complication) Non Gangren's diabetic foot ulcer Not Currently pregnant or breastfeeding, fertile women with out using any contraceptives methods Current daily tobacco smoker and Alcohol consumption with out any decision to change diet and physical style Not having a history of cancer less than 5 years and a depression

Exclusion criteria

Exclusion criteria: Evidence of any unwanted side effects of the drug include increased liver enzymes or functional renal dysfunction or Lower blood glucose control in the requested serial tests Evidence of any unwanted gastrointestinal discomfort, such as diarrhea, nausea, or gastrointestinal intolerance of the combined medication Any unwillingness of participants to continue to participate in the plan

Design outcomes

Primary

MeasureTime frame
Fasting Blood Glucose. Timepoint: Before, at the first of study, daily for 3 days, once 2days for 4 days , on the days of 15, 30, 45 and 60. Method of measurement: patients with check fasting blood glucose with Glucometer at Home.

Secondary

MeasureTime frame
Liver Function Test. Timepoint: Before, After, At the end of first month, At the end of second month. Method of measurement: Liver Function Tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhalil Mohamadzadeh

Bagheiat-allah University of Medical Sciences

stu.khalil.mhmd@bmsu.ac.ir+98 21 8805 0436

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026